Top compounds associated with response to ADGRE1


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.0082 0.9
mRNA tivozanib GDSC1000 pan-cancer AAC -0.058 0.09
mRNA tivozanib CTRPv2 pan-cancer AAC 0.048 0.2
mRNA tosedostat CTRPv2 pan-cancer AAC 0.029 0.4
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.02
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.02 0.5
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.019 0.6
mRNA triptolide CTRPv2 pan-cancer AAC 0.016 0.6
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.11 0.0002
Download CSV